world congress of cardiology 2014 melbourne , page-17

On the evidence we have the case to use a CardioCel patch over rival technologies would be a slam dunk. This is why over time, unless a new superior technology eventuates, I would expect that 100% of surgeons (who are able to have access to it) would use it on 100% of patients for who it is applicable.

We all know the advantages and they are so compelling that there really doesn't appear to be even a real choice at hand…. kind of like asking a guest over for dinner whether they'd prefer to eat of a plate or from the floor…..

As Dr Chick (COO) said about the competitive advantages CardioCel exhibits over competitors "is amazing compared to what else is out there." And sure critics will say, but he works for the company! Although it is also his reputation on the line if he makes statements like that which don't eventuate and going by his stellar career and achievements I'd say that he took his reputation very seriously.